CYP — Cynata Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- AU$43.92m
- AU$33.41m
- AU$0.42m
Annual balance sheet for Cynata Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 13.7 | 26.7 | 23.8 | 16.2 | 6.21 |
| Net Total Receivables | 0.013 | 0.253 | 0.075 | 0.342 | 0.11 |
| Prepaid Expenses | |||||
| Total Current Assets | 13.9 | 27.3 | 24.1 | 16.9 | 6.54 |
| Net Intangible Assets | |||||
| Long Term Notes Receivable | |||||
| Total Assets | 17.5 | 30 | 26.5 | 19 | 8.39 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Total Current Liabilities | 0.69 | 1.6 | 2.59 | 2.26 | 1.17 |
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Liabilities | 0.69 | 1.6 | 2.59 | 2.26 | 1.17 |
| Common Stock | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 16.8 | 28.4 | 24 | 16.7 | 7.22 |
| Total Liabilities & Shareholders' Equity | 17.5 | 30 | 26.5 | 19 | 8.39 |
| Total Common Shares Outstanding |